The best-case scenario is that the weight you lose on your scale represents 80% fat mass loss and 20% muscle mass loss
Peptide therapy stimulates your bodys natural pathways instead of replacing them, so the gains you build remain sustainable and compound over months and years
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors to suppress appetite and improve metabolic regulation
10.1056/NEJMoa0803085 86 HallJ
If you choose the sublingual route, understand that you are using a less-studied formulation and monitor your results accordingly
DALYs and mortality related to obesity are the consequence of the multiple comorbidities spanning from cardiovascular (CV) and metabolic diseases, such as heart failure (HF) and type 2 diabetes (T2D), to many cancers, infertility and respiratory (e.g., obstructive apnea syndrome), cutaneous (e.g